The efficacy of adjuvant radioactive iodine after reoperation in patients with persistent or recurrent differentiated thyroid cancer: a systematic review.

Jaivikash RaghupathyBenjamin Kye Jyn TanHarris J J M D SongAlys Z Q ChiaYi Zhao TanSamantha Peiling YangRajeev Parameswaran

Published in: Langenbeck's archives of surgery (2023)

Adjuvant RAI after reoperation in recurrent DTC was not associated with improved cancer or treatment-related outcomes. However, as the included studies were of inadequate quality, there is an urgent need for randomized trials and well-analyzed cohort studies. Physicians should exercise clinical judgment to prescribe adjuvant RAI for only selected, high-risk patients.

Keyphrases

early stage
end stage renal disease
newly diagnosed
primary care
ejection fraction
chronic kidney disease
papillary thyroid
physical activity
prognostic factors
peritoneal dialysis
magnetic resonance imaging
type diabetes
adipose tissue
combination therapy
drug induced
weight loss
glycemic control
contrast enhanced